| abstract |
This invention relates to a method of treating a disease, disorder, or condition in a patient comprising administering to a patient a therapeutically effective amount of a thiazole derivative, tetomilast. The invention further relates to the administration of at least one beta2-adrenergic receptor agonist, with tetomilast for treating a disease, disorder, or condition. The invention further relates to the administration of an anti-inflammatory steroid, with tetomilast and at least one beta2-adrenergic receptor agonist for treating a disease, disorder, or condition. |